Pluot said...
Please read this transcript of a lecture by the CCFA about weighing risks and benefits: www.ccfa.org/assets/pdfs/risk-and-benefits-transcript.pdf. It was very helpful to me when I was scared about starting Remicade. Remicade does increase your risk of lymphoma (and moreso when used in conjunction with another immunomodulator like mtx) but it's a small risk and after being increased it is still a small risk. With unremitting inflammation you're increasing your risk of colon cancer far more than Remicade increases your risk of lymphoma.
Link doesn't work, not sure why, as I have a pdf reader.
Apart from that, just wanted to say thank you for that post. I'm no lover of Remicade. I was in hospital with a serious flare-up a month after starting it, and that was as good as it ever got for me. I have no personal reason to push Remicade whatsoever, other than recognising it does help a lot of other people (just not me).
I recently read a short piece by a doctor despairing about
PILs (Patient Information Leaflets) and the patients who refuse to take antidepressants after reading about
the possible side-effects in them. He was talking specifically about
depression and antidepressants, but the same could be applied to all drugs, even OTC ones. The list of side-effects are always terrifying. That's because by law drug manufacturers are obliged to list every single reported side-effect of a drug. Even if it only happened to one patient. Even if it wasn't caused by the drug, but by something else. If it's reported, it has to be listed.
So take Remicade and brain lesions or MS. Is the probability somebody on Remicade getting brain lesions higher than somebody not on Remicade? By the laws of probability, a few people who are on Remicade are gonna develop MS, but would they have still developed it even if they hadn't been on Remicade?
As for the "doubled" risk of lymphoma, it's been said already, but it bears repeating: the doubling of a tiny risk still makes it a tiny risk, e.g, from 2 in 100,000 to 4 in 100,000. Simply having IBD itself increases the risk for lymphoma, so some of the cases which occur on Remicade may have happened because of having IBD rather than being on Remicade. That said, the overall probability for getting lymphoma if you have IBD/are on Remicade, is still very low.
Last but not least: uncontrolled colitis eventually leads to a far, far greater chance of colon cancer than Remicade does of lymphoma. After 40 years of colitis we are talking about
a 50% chance, or 1 in 2 probability, of colon cancer. Now not many people have colitis which isn't in remission for that long; usually they have surgery long before if it's pancolitis, tbh. But am just emphasising that colitis (in particular, pancolitis) is a massive risk for colon cancer in itself.
Oh sorry, have just thought of one more thing <_<. The truly dangerous drug is Prednisone. Being on that and unable to get off it frightened me far more than being on Remicade.
PS: I thought Canada had a public health system, like the UK... =/ Hopefully somebody Canadian can help with the expense issue. In the meantime, might be worth trying low-dose Imuran/6MP with allopurinol, which is meant to reduce toxic side-effects like vomiting and increase the effectiveness of the Imuran/6MP. This seems little known about
, but there are studies which can be found online.